Gene · 4781
Papers2,223
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,223
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| RETRACTED: NFIC suppressed the development of Glioma via modulating the balance of SHP2/PI3K and NF-κB/PTEN Signaling. | PLoS One | 2026 | 41811891 | PubTator, text mining | PubMed |
| Phase Separation of NFIB Suppresses SLC3A2-Mediated Ferroptosis in Castration-Resistant Prostate Cancer. | Adv Sci (Weinh) | 2026 | 41801221 | PubTator, text mining | PubMed |
| Prognostic stratification in hepatocellular carcinoma using a telomerase-related lncRNA signature derived from TCGA database. | PLoS One | 2026 | 41790716 | PubTator, text mining | PubMed |
| An unusual case of adenoid cystic carcinoma presenting with isolated liver metastasis: A case report. | Medicine (Baltimore) | 2026 | 41790683 | PubTator, text mining | PubMed |
| Basaloid-Solid Adenoid Cystic Carcinoma of the Breast: A Case Report and Literature Review. | Case Rep Pathol | 2026 | 41783379 | PubTator, text mining | PubMed |
| Functional roles and mechanisms of circRNA-protein interactions in cancer progression and tumor immune regulation. | Front Immunol | 2026 | 41756268 | PubTator, text mining | PubMed |
| Targeting the Endoplasmic Reticulum Oxidoreductin-1 Alpha-Protein Disulfide Isomerase Redox Interface as a Therapeutic Strategy in Cancer. | Biomedicines | 2026 | 41751162 | PubTator, text mining | PubMed |
| A Comprehensive Adenoid Cystic Carcinoma-Derived Organoid Platform for Disease Modeling and Drug Screening Captures Interpatient Heterogeneity. | Cells | 2026 | 41744826 | PubTator, text mining | PubMed |
| Forward programming of human pluripotent stem cells to generate glutamatergic and GABAergic neurons in a tri-culture model with astrocytes. | Stem Cell Res Ther | 2026 | 41742306 | PubTator, text mining | PubMed |
| Transcriptional and epigenetic reprogramming, lineage plasticity and therapy resistance in prostate cancer. | J Natl Cancer Cent | 2026 | 41738031 | PubTator, text mining | PubMed |
| Mixed Invasive Adenoid Cystic and Lobular Carcinoma of the Breast: A Case Report of a Rare Hybrid Tumor. | Cureus | 2026 | 41728528 | PubTator, text mining | PubMed |
| Insights Into circRNA-Mediated Lipid Metabolism in Cancer Progression. | J Cell Mol Med | 2026 | 41652992 | PubTator, text mining | PubMed |
| Resolving clonal evolution and selection of extrachromosomal DNA at single-cell resolution. | Genome Biol | 2026 | 41606654 | PubTator, text mining | PubMed |
| The GF-NEO discovery platform unveils a [KQE][DG] sequence motif within fusion neoantigens in pediatric cancer. | iScience | 2026 | 41567246 | PubTator, text mining | PubMed |
| A tailored histology-driven molecular profiling algorithm proposal for salivary gland cancers. | ESMO Open | 2026 | 41547215 | PubTator, text mining | PubMed |
| Nuclear Factor I-B Delays Liver Fibrosis by Inhibiting Chemokine Ligand 5 Transcription. | Adv Sci (Weinh) | 2026 | 41436407 | PubTator, text mining | PubMed |
| [Nuclear Factor I-X Regulates Molecular Pathways Related to Craniofacial Development Through Phase Separation]. | Sichuan Da Xue Xue Bao Yi Xue Ban | 2025 | 41536686 | PubTator, text mining | PubMed |
| Molecular basis of NFIB-mediated regulation of oncogenic transcription. | Nucleic Acids Res | 2025 | 41428734 | PubTator, text mining | PubMed |
| Adenoid Cystic Carcinoma of Breast-A Narrative Review. | Indian J Surg Oncol | 2025 | 41415789 | PubTator, text mining | PubMed |
| NFIB rs28379954 does not affect CYP2D6-mediated metabolism of prototypical substrates, tamoxifen or solanidine. | Pharmacogenet Genomics | 2025 | 41399021 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4781/papers?page=2